Latest News and Press Releases
Want to stay updated on the latest news?
-
Ancilia has been awarded $3M from the prestigious ARPA-H Sprint for Women’s Health to develop a novel therapy for bacterial vaginosis through IND filing.
-
Ancilia raised $4.2M to leverage CRISPR’s natural function to create bacterial therapies with immunity against the viruses that limit their effectiveness.